SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John O'Neill who wrote (157)9/4/1998 7:06:00 PM
From: WTDEC   of 415
 
Hello JO. I'm still here waiting for $9 to look like it was a good buy. MCDE has plenty of cash so there should be no need for them to do any new issuance at these crummy levels. Maybe they will take a cue from GLFD and buy some shares back with all the cash they have. In any case, I have a nice cash inflow due soon and hope to buy more. Maybe I'll get it at less than the cash value per share...$3.20 per share .... if this market mania continues. Roughly 80 cents per share for the technology and R&D developments here is the bargain of a lifetime and there are numerous such bargains in biotechland today!

Meanwhile, the business is right on target as you indicate. Hope all is well with you.

Best regards,

Walter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext